Stay updated on U3-1402 in NSCLC Clinical Trial
Sign up to get notified when there's something new on the U3-1402 in NSCLC Clinical Trial page.
Latest updates to the U3-1402 in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe 'Last Update Posted (Estimated)' label was changed to 'Last Update Posted' on the Study Details page.SummaryDifference0.0%
- Check9 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 in the page footer; no observable changes to the study details, content, layout, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedAdded a Locations section listing trial sites by state (California, Georgia, Massachusetts, Michigan, New York, Ohio, Pennsylvania, Tennessee, Texas, Washington). Updated page revision to v3.3.3 and removed the previous state-specific location blocks and the HHS Vulnerability Disclosure link.SummaryDifference0.6%
- Check60 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check67 days agoChange Detected- The government funding status notice about potential delays and updates has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check74 days agoChange DetectedUpdated the study location entry from 'Tainan City, Taiwan, 00704' to 'Tainan, Taiwan, 00704'.SummaryDifference0.0%
Stay in the know with updates to U3-1402 in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the U3-1402 in NSCLC Clinical Trial page.